| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vaccination | 125 | 2026 | 1428 | 19.570 |
Why?
|
| Vaccines | 39 | 2026 | 389 | 10.770 |
Why?
|
| Papillomavirus Vaccines | 37 | 2026 | 296 | 8.350 |
Why?
|
| Influenza Vaccines | 44 | 2026 | 534 | 8.230 |
Why?
|
| Immunization | 29 | 2025 | 375 | 5.930 |
Why?
|
| Parents | 41 | 2026 | 1407 | 5.520 |
Why?
|
| Health Knowledge, Attitudes, Practice | 41 | 2025 | 1420 | 5.330 |
Why?
|
| Influenza, Human | 27 | 2026 | 624 | 5.240 |
Why?
|
| Papillomavirus Infections | 23 | 2026 | 344 | 5.000 |
Why?
|
| Immunization Programs | 15 | 2025 | 193 | 4.630 |
Why?
|
| Motivational Interviewing | 12 | 2025 | 121 | 4.470 |
Why?
|
| Vaccination Refusal | 14 | 2022 | 61 | 4.360 |
Why?
|
| Obstetrics | 14 | 2022 | 177 | 4.120 |
Why?
|
| Gynecology | 13 | 2022 | 181 | 3.880 |
Why?
|
| Attitude of Health Personnel | 32 | 2026 | 1197 | 3.590 |
Why?
|
| Patient Acceptance of Health Care | 26 | 2025 | 883 | 3.440 |
Why?
|
| Practice Patterns, Physicians' | 25 | 2024 | 1372 | 3.220 |
Why?
|
| Advisory Committees | 20 | 2025 | 229 | 3.110 |
Why?
|
| Immunization Schedule | 22 | 2025 | 186 | 3.050 |
Why?
|
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 12 | 2022 | 91 | 3.020 |
Why?
|
| Respiratory Syncytial Virus Vaccines | 9 | 2025 | 39 | 2.900 |
Why?
|
| Vaccination Coverage | 11 | 2026 | 102 | 2.860 |
Why?
|
| Meningococcal Vaccines | 13 | 2025 | 57 | 2.830 |
Why?
|
| Pregnancy Complications, Infectious | 8 | 2023 | 440 | 2.570 |
Why?
|
| Humans | 269 | 2026 | 145763 | 2.480 |
Why?
|
| Child | 95 | 2026 | 22739 | 2.480 |
Why?
|
| Narration | 3 | 2026 | 80 | 2.450 |
Why?
|
| Clergy | 4 | 2020 | 10 | 2.420 |
Why?
|
| Physicians, Primary Care | 12 | 2024 | 208 | 2.390 |
Why?
|
| Colorado | 43 | 2026 | 4556 | 2.360 |
Why?
|
| Communication | 16 | 2026 | 977 | 2.190 |
Why?
|
| Health Personnel | 14 | 2024 | 757 | 2.150 |
Why?
|
| Neurosurgical Procedures | 8 | 2026 | 202 | 2.150 |
Why?
|
| Hepatitis B | 4 | 2023 | 66 | 2.010 |
Why?
|
| Caregivers | 5 | 2026 | 1074 | 2.000 |
Why?
|
| Female | 161 | 2026 | 79035 | 1.930 |
Why?
|
| Pediatrics | 17 | 2026 | 1125 | 1.930 |
Why?
|
| Infant | 56 | 2026 | 10090 | 1.880 |
Why?
|
| Pediatricians | 9 | 2024 | 121 | 1.790 |
Why?
|
| Religion | 3 | 2020 | 65 | 1.780 |
Why?
|
| Health Communication | 4 | 2021 | 53 | 1.770 |
Why?
|
| Viral Vaccines | 4 | 2024 | 107 | 1.760 |
Why?
|
| Pregnancy | 48 | 2026 | 7215 | 1.750 |
Why?
|
| Adult | 93 | 2026 | 40872 | 1.660 |
Why?
|
| Whooping Cough | 6 | 2022 | 55 | 1.650 |
Why?
|
| United States | 63 | 2026 | 16123 | 1.640 |
Why?
|
| Attitude to Health | 9 | 2020 | 430 | 1.640 |
Why?
|
| Reminder Systems | 5 | 2026 | 140 | 1.600 |
Why?
|
| Adolescent | 71 | 2026 | 22573 | 1.600 |
Why?
|
| Respiratory Syncytial Virus Infections | 6 | 2025 | 139 | 1.540 |
Why?
|
| Male | 114 | 2026 | 73003 | 1.430 |
Why?
|
| Physician-Patient Relations | 6 | 2026 | 588 | 1.400 |
Why?
|
| Emergency Service, Hospital | 5 | 2025 | 2383 | 1.310 |
Why?
|
| Brain Neoplasms | 5 | 2026 | 1331 | 1.280 |
Why?
|
| Social Media | 4 | 2021 | 167 | 1.240 |
Why?
|
| Treatment Refusal | 5 | 2020 | 99 | 1.230 |
Why?
|
| Child, Preschool | 38 | 2026 | 11868 | 1.220 |
Why?
|
| Primary Health Care | 14 | 2024 | 1737 | 1.200 |
Why?
|
| Suicide | 3 | 2025 | 729 | 1.170 |
Why?
|
| Surveys and Questionnaires | 34 | 2025 | 6085 | 1.160 |
Why?
|
| Health Promotion | 5 | 2020 | 775 | 1.100 |
Why?
|
| Physicians, Family | 10 | 2021 | 177 | 1.090 |
Why?
|
| Adolescent Health Services | 4 | 2015 | 74 | 1.070 |
Why?
|
| Pseudotumor Cerebri | 2 | 2025 | 32 | 1.060 |
Why?
|
| Mass Screening | 3 | 2025 | 1361 | 1.060 |
Why?
|
| Middle Aged | 60 | 2026 | 36302 | 1.060 |
Why?
|
| Anterior Cruciate Ligament Reconstruction | 6 | 2024 | 193 | 1.020 |
Why?
|
| Osteomyelitis | 3 | 2026 | 146 | 1.000 |
Why?
|
| Safety-net Providers | 3 | 2025 | 130 | 0.980 |
Why?
|
| Measles | 4 | 2022 | 46 | 0.960 |
Why?
|
| Trust | 5 | 2026 | 158 | 0.950 |
Why?
|
| Prenatal Care | 2 | 2020 | 309 | 0.950 |
Why?
|
| Qualitative Research | 12 | 2025 | 1683 | 0.950 |
Why?
|
| Practice Guidelines as Topic | 12 | 2025 | 1582 | 0.920 |
Why?
|
| Spinal Cord | 2 | 2025 | 382 | 0.910 |
Why?
|
| Physicians | 11 | 2022 | 956 | 0.900 |
Why?
|
| Diphtheria | 4 | 2022 | 21 | 0.900 |
Why?
|
| Patient Outcome Assessment | 2 | 2019 | 130 | 0.900 |
Why?
|
| Tetanus | 4 | 2022 | 26 | 0.900 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2025 | 27 | 0.900 |
Why?
|
| Measles-Mumps-Rubella Vaccine | 3 | 2022 | 48 | 0.890 |
Why?
|
| Infectious Disease Transmission, Vertical | 4 | 2023 | 194 | 0.890 |
Why?
|
| Rural Health Services | 2 | 2024 | 138 | 0.890 |
Why?
|
| Stereotaxic Techniques | 1 | 2025 | 42 | 0.880 |
Why?
|
| Radiosurgery | 2 | 2026 | 399 | 0.880 |
Why?
|
| Arthritis, Infectious | 2 | 2026 | 76 | 0.880 |
Why?
|
| Respiratory Syncytial Virus, Human | 2 | 2025 | 81 | 0.880 |
Why?
|
| Knee Prosthesis | 1 | 2025 | 28 | 0.870 |
Why?
|
| Health Care Surveys | 12 | 2021 | 536 | 0.860 |
Why?
|
| Policy | 3 | 2020 | 149 | 0.860 |
Why?
|
| Glioma | 2 | 2026 | 429 | 0.860 |
Why?
|
| Bone Cysts, Aneurysmal | 1 | 2024 | 2 | 0.850 |
Why?
|
| Prosthesis Failure | 1 | 2025 | 125 | 0.840 |
Why?
|
| Preventive Health Services | 3 | 2025 | 153 | 0.840 |
Why?
|
| Immunotherapy | 2 | 2026 | 667 | 0.830 |
Why?
|
| Spinal Dysraphism | 1 | 2026 | 110 | 0.830 |
Why?
|
| Pandemics | 6 | 2024 | 1711 | 0.830 |
Why?
|
| Orbital Diseases | 1 | 2024 | 37 | 0.820 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2026 | 266 | 0.810 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2024 | 70 | 0.810 |
Why?
|
| Community Participation | 2 | 2025 | 123 | 0.810 |
Why?
|
| Anterior Cruciate Ligament Injuries | 5 | 2024 | 218 | 0.790 |
Why?
|
| Laser Therapy | 1 | 2025 | 144 | 0.770 |
Why?
|
| Schools | 3 | 2025 | 449 | 0.770 |
Why?
|
| Arthroplasty, Replacement, Knee | 2 | 2025 | 376 | 0.760 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2025 | 177 | 0.750 |
Why?
|
| Religion and Medicine | 2 | 2019 | 33 | 0.740 |
Why?
|
| Ambulatory Care | 4 | 2020 | 610 | 0.730 |
Why?
|
| Prefrontal Cortex | 1 | 2025 | 336 | 0.730 |
Why?
|
| Developing Countries | 1 | 2024 | 317 | 0.730 |
Why?
|
| Lipid Metabolism | 1 | 2025 | 529 | 0.710 |
Why?
|
| Health Services Research | 4 | 2019 | 391 | 0.700 |
Why?
|
| Health Equity | 1 | 2024 | 133 | 0.700 |
Why?
|
| Young Adult | 28 | 2026 | 14251 | 0.700 |
Why?
|
| Hepatitis B Vaccines | 4 | 2023 | 43 | 0.690 |
Why?
|
| Arachnoid Cysts | 3 | 2026 | 10 | 0.690 |
Why?
|
| Refusal to Treat | 2 | 2020 | 16 | 0.680 |
Why?
|
| Suicide, Attempted | 1 | 2025 | 426 | 0.680 |
Why?
|
| Infant, Newborn | 17 | 2025 | 6464 | 0.680 |
Why?
|
| Urban Population | 4 | 2024 | 494 | 0.670 |
Why?
|
| Herpes Zoster Vaccine | 6 | 2022 | 154 | 0.670 |
Why?
|
| Cochlear Implantation | 1 | 2022 | 83 | 0.670 |
Why?
|
| Cochlear Implants | 1 | 2022 | 96 | 0.670 |
Why?
|
| Global Health | 1 | 2024 | 403 | 0.670 |
Why?
|
| Private Practice | 1 | 2020 | 17 | 0.660 |
Why?
|
| Pneumococcal Vaccines | 6 | 2021 | 129 | 0.660 |
Why?
|
| Rural Population | 6 | 2024 | 661 | 0.650 |
Why?
|
| Standing Orders | 2 | 2020 | 10 | 0.650 |
Why?
|
| Streptococcal Vaccines | 2 | 2025 | 7 | 0.640 |
Why?
|
| Professional-Patient Relations | 3 | 2018 | 147 | 0.640 |
Why?
|
| Lipids | 1 | 2025 | 707 | 0.640 |
Why?
|
| School Health Services | 4 | 2026 | 221 | 0.640 |
Why?
|
| Burns | 1 | 2025 | 374 | 0.640 |
Why?
|
| Retrospective Studies | 30 | 2026 | 17325 | 0.640 |
Why?
|
| Registries | 6 | 2026 | 2410 | 0.620 |
Why?
|
| Myocarditis | 1 | 2021 | 102 | 0.620 |
Why?
|
| Anti-Vaccination Movement | 1 | 2019 | 3 | 0.620 |
Why?
|
| Stakeholder Participation | 1 | 2020 | 85 | 0.610 |
Why?
|
| Longevity | 1 | 2021 | 178 | 0.600 |
Why?
|
| Freedom | 1 | 2019 | 15 | 0.600 |
Why?
|
| Health Care Costs | 3 | 2020 | 425 | 0.600 |
Why?
|
| Text Messaging | 3 | 2019 | 182 | 0.600 |
Why?
|
| Treatment Outcome | 17 | 2026 | 11793 | 0.590 |
Why?
|
| Cross-Sectional Studies | 12 | 2024 | 5922 | 0.580 |
Why?
|
| Public Health | 4 | 2024 | 574 | 0.570 |
Why?
|
| Hearing Loss | 1 | 2022 | 249 | 0.570 |
Why?
|
| Chickenpox Vaccine | 3 | 2017 | 76 | 0.570 |
Why?
|
| Healthcare Disparities | 3 | 2024 | 736 | 0.560 |
Why?
|
| Disease Outbreaks | 3 | 2022 | 419 | 0.560 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 159 | 0.560 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2024 | 453 | 0.540 |
Why?
|
| Rotavirus Infections | 2 | 2021 | 37 | 0.540 |
Why?
|
| Rotavirus Vaccines | 2 | 2021 | 39 | 0.540 |
Why?
|
| Information Seeking Behavior | 1 | 2018 | 40 | 0.540 |
Why?
|
| Patient-Centered Care | 3 | 2026 | 547 | 0.540 |
Why?
|
| Down Syndrome | 2 | 2021 | 525 | 0.530 |
Why?
|
| Streptococcal Infections | 2 | 2025 | 171 | 0.530 |
Why?
|
| Aged | 30 | 2026 | 26215 | 0.530 |
Why?
|
| Mothers | 5 | 2022 | 765 | 0.530 |
Why?
|
| Documentation | 2 | 2019 | 199 | 0.520 |
Why?
|
| Patient Preference | 2 | 2017 | 223 | 0.520 |
Why?
|
| Hepatitis A Vaccines | 4 | 2019 | 19 | 0.510 |
Why?
|
| Infertility | 3 | 2023 | 61 | 0.510 |
Why?
|
| Neuroendoscopy | 3 | 2025 | 24 | 0.500 |
Why?
|
| Cues | 1 | 2019 | 329 | 0.500 |
Why?
|
| Propensity Score | 4 | 2026 | 377 | 0.490 |
Why?
|
| Mass Media | 1 | 2016 | 39 | 0.480 |
Why?
|
| Evidence-Based Medicine | 5 | 2024 | 740 | 0.480 |
Why?
|
| Physician's Role | 2 | 2019 | 225 | 0.480 |
Why?
|
| Interviews as Topic | 6 | 2025 | 916 | 0.480 |
Why?
|
| Health Education | 2 | 2018 | 346 | 0.480 |
Why?
|
| Mumps | 3 | 2022 | 21 | 0.480 |
Why?
|
| Cranial Fossa, Middle | 2 | 2026 | 19 | 0.460 |
Why?
|
| Anti-Bacterial Agents | 6 | 2026 | 1925 | 0.460 |
Why?
|
| Delivery of Health Care | 3 | 2023 | 947 | 0.460 |
Why?
|
| Health Policy | 2 | 2025 | 400 | 0.450 |
Why?
|
| Vaccines, Combined | 4 | 2023 | 49 | 0.450 |
Why?
|
| Cost-Benefit Analysis | 4 | 2024 | 644 | 0.440 |
Why?
|
| Computers, Handheld | 1 | 2015 | 26 | 0.440 |
Why?
|
| Postoperative Complications | 6 | 2026 | 2977 | 0.430 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2018 | 268 | 0.420 |
Why?
|
| Dengue Vaccines | 3 | 2019 | 11 | 0.420 |
Why?
|
| Anthrax Vaccines | 3 | 2018 | 7 | 0.420 |
Why?
|
| Hepatitis B Surface Antigens | 2 | 2023 | 17 | 0.400 |
Why?
|
| Recovery of Function | 2 | 2020 | 716 | 0.390 |
Why?
|
| United Kingdom | 6 | 2025 | 358 | 0.380 |
Why?
|
| Internet | 5 | 2019 | 693 | 0.380 |
Why?
|
| Age Factors | 7 | 2026 | 3346 | 0.370 |
Why?
|
| Aged, 80 and over | 10 | 2025 | 8346 | 0.370 |
Why?
|
| Frailty | 2 | 2026 | 205 | 0.370 |
Why?
|
| Seizures, Febrile | 1 | 2012 | 23 | 0.370 |
Why?
|
| Washington | 2 | 2025 | 149 | 0.370 |
Why?
|
| Meningococcal Infections | 3 | 2018 | 26 | 0.360 |
Why?
|
| Herpes Zoster | 3 | 2022 | 319 | 0.360 |
Why?
|
| Nurseries, Hospital | 1 | 2012 | 5 | 0.360 |
Why?
|
| Safety | 2 | 2020 | 358 | 0.360 |
Why?
|
| Infertility, Female | 3 | 2021 | 122 | 0.350 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2012 | 18 | 0.350 |
Why?
|
| Georgia | 6 | 2021 | 79 | 0.350 |
Why?
|
| Anti-Mullerian Hormone | 2 | 2022 | 61 | 0.340 |
Why?
|
| Family Practice | 7 | 2017 | 407 | 0.340 |
Why?
|
| Cohort Studies | 7 | 2026 | 6032 | 0.340 |
Why?
|
| Africa | 3 | 2026 | 119 | 0.340 |
Why?
|
| Community-Based Participatory Research | 2 | 2025 | 168 | 0.340 |
Why?
|
| Staphylococcal Infections | 2 | 2026 | 393 | 0.330 |
Why?
|
| Skin Diseases, Bacterial | 3 | 2016 | 22 | 0.330 |
Why?
|
| Rotator Cuff | 3 | 2009 | 59 | 0.320 |
Why?
|
| Mumps Vaccine | 3 | 2021 | 11 | 0.320 |
Why?
|
| Pertussis Vaccine | 3 | 2022 | 24 | 0.320 |
Why?
|
| Mental Health Services | 2 | 2026 | 475 | 0.310 |
Why?
|
| Attitude | 3 | 2021 | 259 | 0.300 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2022 | 1751 | 0.300 |
Why?
|
| Tenodesis | 1 | 2009 | 20 | 0.300 |
Why?
|
| Hospitalization | 9 | 2025 | 2460 | 0.290 |
Why?
|
| Australia | 4 | 2023 | 291 | 0.290 |
Why?
|
| Japanese Encephalitis Vaccines | 2 | 2018 | 2 | 0.290 |
Why?
|
| Serum Albumin | 2 | 2026 | 147 | 0.280 |
Why?
|
| Vaccines, Contraceptive | 1 | 2008 | 1 | 0.280 |
Why?
|
| Risk Factors | 11 | 2026 | 10917 | 0.280 |
Why?
|
| Tendon Injuries | 1 | 2009 | 73 | 0.280 |
Why?
|
| Egg Proteins | 1 | 2008 | 20 | 0.280 |
Why?
|
| Hepatitis B virus | 2 | 2023 | 33 | 0.280 |
Why?
|
| Ovulation | 1 | 2008 | 46 | 0.280 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 2393 | 0.270 |
Why?
|
| Guideline Adherence | 2 | 2013 | 587 | 0.270 |
Why?
|
| Ovarian Follicle | 1 | 2008 | 78 | 0.270 |
Why?
|
| Skull Base | 2 | 2025 | 55 | 0.260 |
Why?
|
| Cerebral Ventricles | 2 | 2025 | 56 | 0.260 |
Why?
|
| California | 4 | 2026 | 473 | 0.260 |
Why?
|
| Cytomegalovirus | 1 | 2008 | 168 | 0.260 |
Why?
|
| Child Health | 2 | 2019 | 154 | 0.250 |
Why?
|
| Professional-Family Relations | 3 | 2018 | 154 | 0.250 |
Why?
|
| Societies, Medical | 4 | 2019 | 900 | 0.250 |
Why?
|
| Maternal Health Services | 2 | 2019 | 101 | 0.250 |
Why?
|
| Vaccines, Synthetic | 3 | 2022 | 137 | 0.250 |
Why?
|
| Mobile Applications | 2 | 2020 | 199 | 0.250 |
Why?
|
| Respiratory Syncytial Viruses | 2 | 2023 | 58 | 0.250 |
Why?
|
| Databases, Factual | 4 | 2025 | 1491 | 0.240 |
Why?
|
| Logistic Models | 3 | 2021 | 2139 | 0.240 |
Why?
|
| Data Collection | 3 | 2014 | 643 | 0.240 |
Why?
|
| Receptors, Cell Surface | 1 | 2008 | 372 | 0.240 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2026 | 251 | 0.240 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2026 | 72 | 0.230 |
Why?
|
| Hematoma, Subdural, Chronic | 1 | 2025 | 4 | 0.230 |
Why?
|
| Craniotomy | 1 | 2026 | 84 | 0.230 |
Why?
|
| Membrane Glycoproteins | 1 | 2008 | 499 | 0.230 |
Why?
|
| Arthroplasty | 2 | 2003 | 59 | 0.230 |
Why?
|
| Early Ambulation | 1 | 2025 | 25 | 0.230 |
Why?
|
| Polyethylene | 1 | 2025 | 13 | 0.230 |
Why?
|
| Acetazolamide | 1 | 2025 | 26 | 0.220 |
Why?
|
| Pneumocephalus | 1 | 2025 | 5 | 0.220 |
Why?
|
| Child Care | 1 | 2025 | 37 | 0.220 |
Why?
|
| Blood Transfusion | 2 | 2025 | 409 | 0.220 |
Why?
|
| Cerebrospinal Fluid Rhinorrhea | 1 | 2024 | 10 | 0.220 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2025 | 71 | 0.220 |
Why?
|
| Shoulder Joint | 2 | 2008 | 199 | 0.220 |
Why?
|
| Privacy | 1 | 2025 | 41 | 0.220 |
Why?
|
| Medically Underserved Area | 1 | 2025 | 100 | 0.220 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2025 | 53 | 0.220 |
Why?
|
| Benchmarking | 1 | 2026 | 191 | 0.220 |
Why?
|
| Antibodies, Bacterial | 1 | 2025 | 147 | 0.220 |
Why?
|
| Blood Coagulation Factors | 1 | 2025 | 71 | 0.210 |
Why?
|
| Craniosynostoses | 1 | 2025 | 69 | 0.210 |
Why?
|
| Haemophilus Vaccines | 1 | 2024 | 29 | 0.210 |
Why?
|
| Spine | 1 | 2026 | 182 | 0.210 |
Why?
|
| Cerebral Hemorrhage | 1 | 2025 | 125 | 0.210 |
Why?
|
| Community Health Centers | 1 | 2024 | 59 | 0.210 |
Why?
|
| Syndrome | 1 | 2025 | 381 | 0.210 |
Why?
|
| Astrocytoma | 1 | 2025 | 130 | 0.210 |
Why?
|
| Intracranial Hemorrhages | 1 | 2025 | 106 | 0.210 |
Why?
|
| Time Factors | 4 | 2020 | 7133 | 0.210 |
Why?
|
| Acne Vulgaris | 1 | 2024 | 25 | 0.210 |
Why?
|
| Disease Management | 2 | 2025 | 653 | 0.200 |
Why?
|
| Pregnancy Rate | 5 | 2023 | 81 | 0.200 |
Why?
|
| Absenteeism | 1 | 2024 | 52 | 0.200 |
Why?
|
| Patellar Ligament | 1 | 2024 | 27 | 0.200 |
Why?
|
| Analgesics | 1 | 2026 | 231 | 0.200 |
Why?
|
| Orbit | 1 | 2024 | 66 | 0.200 |
Why?
|
| Home Health Aides | 1 | 2023 | 6 | 0.200 |
Why?
|
| Streptococcus agalactiae | 1 | 2025 | 110 | 0.200 |
Why?
|
| Empathy | 1 | 2026 | 181 | 0.200 |
Why?
|
| Seasons | 2 | 2020 | 538 | 0.200 |
Why?
|
| Tibia | 1 | 2025 | 176 | 0.200 |
Why?
|
| Bacterial Vaccines | 1 | 2024 | 63 | 0.200 |
Why?
|
| Prosthesis Design | 2 | 2025 | 356 | 0.200 |
Why?
|
| Stroke | 2 | 2025 | 1271 | 0.200 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2024 | 85 | 0.200 |
Why?
|
| Cerebrovascular Disorders | 1 | 2024 | 105 | 0.200 |
Why?
|
| Patient Education as Topic | 2 | 2019 | 777 | 0.200 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2025 | 276 | 0.200 |
Why?
|
| Musculoskeletal Diseases | 1 | 2025 | 91 | 0.200 |
Why?
|
| Blood Coagulation Tests | 1 | 2023 | 72 | 0.200 |
Why?
|
| Nutritional Status | 1 | 2026 | 353 | 0.200 |
Why?
|
| Pituitary Neoplasms | 1 | 2025 | 190 | 0.190 |
Why?
|
| Prospective Studies | 5 | 2022 | 8075 | 0.190 |
Why?
|
| Perioperative Care | 1 | 2025 | 231 | 0.190 |
Why?
|
| Decision Making | 3 | 2020 | 982 | 0.190 |
Why?
|
| Audiometry, Evoked Response | 1 | 2022 | 15 | 0.190 |
Why?
|
| Silicone Elastomers | 1 | 2002 | 7 | 0.190 |
Why?
|
| Oxytocics | 1 | 2022 | 15 | 0.190 |
Why?
|
| Gout | 1 | 2003 | 34 | 0.190 |
Why?
|
| Reoperation | 2 | 2025 | 637 | 0.190 |
Why?
|
| Biological Transport | 1 | 2024 | 424 | 0.190 |
Why?
|
| Joint Prosthesis | 1 | 2002 | 22 | 0.190 |
Why?
|
| Hospitals | 3 | 2023 | 733 | 0.180 |
Why?
|
| Prostaglandins | 1 | 2022 | 94 | 0.180 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2024 | 140 | 0.180 |
Why?
|
| Suicidal Ideation | 2 | 2025 | 583 | 0.180 |
Why?
|
| Thumb | 1 | 2002 | 37 | 0.180 |
Why?
|
| Diagnostic Imaging | 1 | 2025 | 337 | 0.180 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 2022 | 15 | 0.180 |
Why?
|
| Ovulation Induction | 2 | 2022 | 65 | 0.180 |
Why?
|
| Pilot Projects | 2 | 2026 | 1897 | 0.180 |
Why?
|
| Cochlea | 1 | 2022 | 73 | 0.180 |
Why?
|
| Pain Management | 1 | 2026 | 411 | 0.180 |
Why?
|
| Rubella | 1 | 2022 | 23 | 0.180 |
Why?
|
| Algorithms | 3 | 2025 | 1850 | 0.180 |
Why?
|
| NF-kappa B | 1 | 2025 | 667 | 0.180 |
Why?
|
| Case-Control Studies | 3 | 2025 | 3634 | 0.180 |
Why?
|
| Neisseria meningitidis, Serogroup B | 2 | 2018 | 15 | 0.180 |
Why?
|
| Orthopedic Procedures | 2 | 2023 | 244 | 0.180 |
Why?
|
| Infant Health | 1 | 2022 | 24 | 0.170 |
Why?
|
| Antibodies, Monoclonal, Humanized | 2 | 2025 | 992 | 0.170 |
Why?
|
| Uterine Diseases | 1 | 2021 | 18 | 0.170 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2023 | 183 | 0.170 |
Why?
|
| Intrauterine Devices | 1 | 2021 | 29 | 0.170 |
Why?
|
| Russia | 1 | 2021 | 12 | 0.170 |
Why?
|
| Intention | 2 | 2020 | 186 | 0.170 |
Why?
|
| Knee Injuries | 1 | 2022 | 122 | 0.170 |
Why?
|
| Automobile Driving | 1 | 2023 | 157 | 0.170 |
Why?
|
| Yellow Fever Vaccine | 2 | 2017 | 7 | 0.170 |
Why?
|
| Risk | 2 | 2015 | 923 | 0.170 |
Why?
|
| Fertilization in Vitro | 4 | 2023 | 108 | 0.170 |
Why?
|
| Regression Analysis | 2 | 2020 | 1001 | 0.170 |
Why?
|
| Live Birth | 4 | 2023 | 81 | 0.170 |
Why?
|
| Germany | 1 | 2021 | 138 | 0.160 |
Why?
|
| Demography | 2 | 2024 | 282 | 0.160 |
Why?
|
| Hospital Rapid Response Team | 1 | 2021 | 20 | 0.160 |
Why?
|
| General Practitioners | 1 | 2021 | 26 | 0.160 |
Why?
|
| Complementary Therapies | 1 | 2022 | 96 | 0.160 |
Why?
|
| Cluster Analysis | 2 | 2022 | 501 | 0.160 |
Why?
|
| Age Distribution | 1 | 2021 | 404 | 0.160 |
Why?
|
| Antiviral Agents | 2 | 2023 | 769 | 0.160 |
Why?
|
| Triage | 1 | 2023 | 250 | 0.160 |
Why?
|
| Ventriculostomy | 1 | 2000 | 24 | 0.160 |
Why?
|
| Cytokines | 2 | 2025 | 2069 | 0.160 |
Why?
|
| Internal Medicine | 2 | 2014 | 279 | 0.160 |
Why?
|
| Anterior Cruciate Ligament | 2 | 2024 | 101 | 0.150 |
Why?
|
| Measles Vaccine | 1 | 2019 | 19 | 0.150 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2025 | 2525 | 0.150 |
Why?
|
| Osteoarthritis | 1 | 2002 | 200 | 0.150 |
Why?
|
| Drug Storage | 1 | 2020 | 53 | 0.150 |
Why?
|
| Hyperglycemia | 1 | 2024 | 379 | 0.150 |
Why?
|
| Norovirus | 1 | 2020 | 22 | 0.150 |
Why?
|
| Thrombosis | 1 | 2024 | 400 | 0.150 |
Why?
|
| Fever | 1 | 2021 | 319 | 0.150 |
Why?
|
| Eligibility Determination | 1 | 2020 | 72 | 0.150 |
Why?
|
| Clinical Competence | 2 | 2018 | 1247 | 0.150 |
Why?
|
| Government Regulation | 1 | 2019 | 39 | 0.150 |
Why?
|
| Reimbursement Mechanisms | 1 | 2020 | 79 | 0.150 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2020 | 98 | 0.150 |
Why?
|
| State Government | 1 | 2019 | 46 | 0.150 |
Why?
|
| Endovascular Procedures | 1 | 2024 | 390 | 0.150 |
Why?
|
| Pennsylvania | 1 | 2019 | 138 | 0.150 |
Why?
|
| von Willebrand Factor | 1 | 2019 | 85 | 0.150 |
Why?
|
| Motivation | 1 | 2024 | 602 | 0.150 |
Why?
|
| Gastroenteritis | 1 | 2020 | 63 | 0.150 |
Why?
|
| Medicaid | 2 | 2021 | 467 | 0.140 |
Why?
|
| Insurance, Health, Reimbursement | 2 | 2017 | 98 | 0.140 |
Why?
|
| Therapeutic Uses | 1 | 2018 | 1 | 0.140 |
Why?
|
| Morbidity | 1 | 2020 | 322 | 0.140 |
Why?
|
| Europe | 1 | 2020 | 421 | 0.140 |
Why?
|
| Insemination, Artificial | 1 | 2018 | 12 | 0.140 |
Why?
|
| Clomiphene | 1 | 2018 | 16 | 0.140 |
Why?
|
| Fertility Agents, Female | 1 | 2018 | 23 | 0.140 |
Why?
|
| Pulmonary Alveoli | 1 | 2021 | 387 | 0.140 |
Why?
|
| Thromboembolism | 1 | 2019 | 129 | 0.140 |
Why?
|
| Melanoma | 1 | 2025 | 761 | 0.140 |
Why?
|
| Urban Health Services | 1 | 2018 | 69 | 0.140 |
Why?
|
| Machine Learning | 2 | 2025 | 587 | 0.140 |
Why?
|
| Smoking | 1 | 2025 | 1477 | 0.130 |
Why?
|
| Education, Continuing | 1 | 2018 | 42 | 0.130 |
Why?
|
| Hearing Loss, Sudden | 1 | 2018 | 12 | 0.130 |
Why?
|
| Nuclear Family | 1 | 2018 | 50 | 0.130 |
Why?
|
| Skin Neoplasms | 1 | 2025 | 852 | 0.130 |
Why?
|
| Placentation | 1 | 2017 | 52 | 0.130 |
Why?
|
| Evidence-Based Practice | 2 | 2020 | 231 | 0.130 |
Why?
|
| Guatemala | 4 | 2020 | 343 | 0.130 |
Why?
|
| Altitude | 1 | 2021 | 463 | 0.130 |
Why?
|
| Trace Elements | 1 | 2017 | 52 | 0.130 |
Why?
|
| Cervical Plexus | 1 | 1997 | 3 | 0.130 |
Why?
|
| Ambulatory Care Facilities | 2 | 2019 | 269 | 0.130 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2018 | 73 | 0.130 |
Why?
|
| Rats | 1 | 2025 | 5585 | 0.120 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2017 | 81 | 0.120 |
Why?
|
| Quality Improvement | 3 | 2020 | 1296 | 0.120 |
Why?
|
| Spinal Nerve Roots | 1 | 1997 | 29 | 0.120 |
Why?
|
| Pneumococcal Infections | 1 | 2018 | 104 | 0.120 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 1547 | 0.120 |
Why?
|
| Body Mass Index | 1 | 2025 | 2447 | 0.120 |
Why?
|
| Morphogenesis | 1 | 2017 | 171 | 0.120 |
Why?
|
| Administrative Personnel | 1 | 2016 | 33 | 0.120 |
Why?
|
| Travel | 1 | 2017 | 136 | 0.120 |
Why?
|
| Physician Executives | 1 | 2016 | 30 | 0.120 |
Why?
|
| Allied Health Personnel | 1 | 2016 | 53 | 0.120 |
Why?
|
| Vaccines, Conjugate | 2 | 2018 | 59 | 0.120 |
Why?
|
| Telemedicine | 1 | 2025 | 966 | 0.120 |
Why?
|
| Cost of Illness | 2 | 2018 | 324 | 0.120 |
Why?
|
| Public Health Practice | 1 | 2016 | 63 | 0.120 |
Why?
|
| Blood Platelets | 1 | 2019 | 379 | 0.120 |
Why?
|
| Diphtheria Toxoid | 1 | 2015 | 13 | 0.120 |
Why?
|
| Adaptation, Psychological | 2 | 2020 | 719 | 0.120 |
Why?
|
| Tetanus Toxoid | 1 | 2015 | 34 | 0.120 |
Why?
|
| Brain Ischemia | 1 | 2019 | 359 | 0.120 |
Why?
|
| Hemorrhage | 1 | 2021 | 822 | 0.120 |
Why?
|
| Behavior Therapy | 1 | 2019 | 296 | 0.110 |
Why?
|
| Herpesvirus 3, Human | 1 | 2019 | 343 | 0.110 |
Why?
|
| Equipment and Supplies | 1 | 2015 | 37 | 0.110 |
Why?
|
| Minority Groups | 1 | 2018 | 285 | 0.110 |
Why?
|
| Curriculum | 1 | 2023 | 1074 | 0.110 |
Why?
|
| Intention to Treat Analysis | 1 | 2015 | 79 | 0.110 |
Why?
|
| Incidence | 2 | 2020 | 2933 | 0.110 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2018 | 188 | 0.110 |
Why?
|
| Patient Participation | 1 | 2019 | 446 | 0.110 |
Why?
|
| Postpartum Period | 1 | 2018 | 373 | 0.110 |
Why?
|
| Information Dissemination | 1 | 2017 | 224 | 0.110 |
Why?
|
| Focus Groups | 5 | 2018 | 572 | 0.110 |
Why?
|
| Cooperative Behavior | 3 | 2014 | 463 | 0.110 |
Why?
|
| Zika Virus Infection | 1 | 2017 | 172 | 0.110 |
Why?
|
| Mutation | 1 | 2026 | 4090 | 0.110 |
Why?
|
| Leadership | 1 | 2019 | 402 | 0.110 |
Why?
|
| Disease Models, Animal | 1 | 2025 | 4568 | 0.110 |
Why?
|
| Health Services Accessibility | 2 | 2024 | 1101 | 0.110 |
Why?
|
| Occupational Health Services | 1 | 2014 | 37 | 0.110 |
Why?
|
| Lung Diseases | 1 | 2021 | 782 | 0.110 |
Why?
|
| Neck Pain | 1 | 2014 | 30 | 0.110 |
Why?
|
| Zinc | 1 | 2017 | 307 | 0.100 |
Why?
|
| Acute Disease | 4 | 2025 | 1036 | 0.100 |
Why?
|
| Pre-Exposure Prophylaxis | 1 | 2017 | 269 | 0.100 |
Why?
|
| Nurses | 1 | 2016 | 171 | 0.100 |
Why?
|
| Prevalence | 1 | 2021 | 2874 | 0.100 |
Why?
|
| Poverty | 1 | 2018 | 529 | 0.100 |
Why?
|
| Public Health Administration | 1 | 2014 | 70 | 0.100 |
Why?
|
| Animals | 5 | 2025 | 38097 | 0.100 |
Why?
|
| State Medicine | 2 | 2024 | 26 | 0.100 |
Why?
|
| Sexual Behavior | 1 | 2018 | 495 | 0.100 |
Why?
|
| Circovirus | 1 | 2013 | 5 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2025 | 2191 | 0.100 |
Why?
|
| Social Behavior | 1 | 2015 | 284 | 0.100 |
Why?
|
| Adolescent Behavior | 1 | 2018 | 497 | 0.090 |
Why?
|
| Intussusception | 1 | 2013 | 26 | 0.090 |
Why?
|
| Drug Contamination | 1 | 2013 | 54 | 0.090 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2013 | 74 | 0.090 |
Why?
|
| Serogroup | 2 | 2025 | 45 | 0.090 |
Why?
|
| Fertilization | 2 | 2023 | 43 | 0.090 |
Why?
|
| Hemodynamics | 1 | 2017 | 1118 | 0.090 |
Why?
|
| Clinical Decision-Making | 3 | 2021 | 364 | 0.090 |
Why?
|
| Risk Assessment | 5 | 2026 | 3752 | 0.090 |
Why?
|
| Workplace | 1 | 2014 | 272 | 0.090 |
Why?
|
| Parent-Child Relations | 1 | 2015 | 271 | 0.090 |
Why?
|
| Brain | 1 | 2024 | 2969 | 0.090 |
Why?
|
| Neisseria meningitidis | 1 | 2011 | 23 | 0.090 |
Why?
|
| Obesity | 1 | 2025 | 3118 | 0.090 |
Why?
|
| Professional Practice Location | 1 | 2011 | 26 | 0.090 |
Why?
|
| Follow-Up Studies | 3 | 2020 | 5428 | 0.090 |
Why?
|
| Patient Compliance | 1 | 2016 | 588 | 0.090 |
Why?
|
| Community-Institutional Relations | 1 | 2012 | 100 | 0.090 |
Why?
|
| Perinatal Care | 1 | 2012 | 59 | 0.080 |
Why?
|
| Outpatients | 1 | 2015 | 447 | 0.080 |
Why?
|
| Placenta | 1 | 2017 | 787 | 0.080 |
Why?
|
| Electronic Health Records | 1 | 2019 | 1202 | 0.080 |
Why?
|
| Sensitivity and Specificity | 3 | 2025 | 2000 | 0.080 |
Why?
|
| Predictive Value of Tests | 2 | 2026 | 2123 | 0.080 |
Why?
|
| Birth Rate | 2 | 2022 | 31 | 0.080 |
Why?
|
| Prognosis | 3 | 2026 | 4329 | 0.080 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2010 | 47 | 0.080 |
Why?
|
| Swine | 1 | 2013 | 826 | 0.080 |
Why?
|
| Pain Measurement | 1 | 2012 | 562 | 0.080 |
Why?
|
| Sports | 1 | 2012 | 212 | 0.080 |
Why?
|
| Hospices | 1 | 2011 | 93 | 0.080 |
Why?
|
| Quality of Life | 3 | 2024 | 3210 | 0.080 |
Why?
|
| Cognition | 1 | 2018 | 1271 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 2602 | 0.070 |
Why?
|
| Activities of Daily Living | 1 | 2012 | 444 | 0.070 |
Why?
|
| Neuromuscular Diseases | 1 | 2011 | 145 | 0.070 |
Why?
|
| Rotator Cuff Injuries | 1 | 2009 | 77 | 0.070 |
Why?
|
| Zona Pellucida Glycoproteins | 1 | 2008 | 2 | 0.070 |
Why?
|
| Growth Differentiation Factor 9 | 1 | 2008 | 4 | 0.070 |
Why?
|
| Communicable Diseases | 2 | 2022 | 166 | 0.070 |
Why?
|
| Connexin 43 | 1 | 2008 | 36 | 0.070 |
Why?
|
| Embryonic Development | 1 | 2008 | 125 | 0.060 |
Why?
|
| Appointments and Schedules | 2 | 2019 | 96 | 0.060 |
Why?
|
| Cell Phone | 2 | 2019 | 82 | 0.060 |
Why?
|
| Tendons | 1 | 2008 | 132 | 0.060 |
Why?
|
| Leukocytes | 1 | 2008 | 296 | 0.060 |
Why?
|
| Ovary | 1 | 2008 | 234 | 0.060 |
Why?
|
| Health Surveys | 2 | 2018 | 520 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 1 | 2008 | 1261 | 0.060 |
Why?
|
| Sphenoid Sinus | 1 | 2025 | 7 | 0.060 |
Why?
|
| Neoplasm Grading | 1 | 2026 | 311 | 0.060 |
Why?
|
| Sphenoid Bone | 1 | 2025 | 15 | 0.060 |
Why?
|
| Central Nervous System Cysts | 1 | 2025 | 13 | 0.060 |
Why?
|
| Fetal Development | 1 | 2008 | 298 | 0.060 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2026 | 365 | 0.050 |
Why?
|
| Blood Loss, Surgical | 1 | 2025 | 113 | 0.050 |
Why?
|
| Antifibrinolytic Agents | 1 | 2025 | 64 | 0.050 |
Why?
|
| Erythropoietin | 1 | 2025 | 100 | 0.050 |
Why?
|
| Immobilization | 1 | 2004 | 54 | 0.050 |
Why?
|
| Tranexamic Acid | 1 | 2025 | 59 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2008 | 523 | 0.050 |
Why?
|
| Tetracyclines | 1 | 2024 | 16 | 0.050 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2024 | 45 | 0.050 |
Why?
|
| Smallpox Vaccine | 1 | 2024 | 23 | 0.050 |
Why?
|
| Electrodes, Implanted | 1 | 2024 | 114 | 0.050 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2024 | 125 | 0.050 |
Why?
|
| Shoulder Dislocation | 1 | 2004 | 61 | 0.050 |
Why?
|
| Palivizumab | 1 | 2023 | 11 | 0.050 |
Why?
|
| Congresses as Topic | 1 | 2025 | 224 | 0.050 |
Why?
|
| Acromion | 1 | 2003 | 8 | 0.050 |
Why?
|
| Ligaments | 1 | 2024 | 76 | 0.050 |
Why?
|
| National Health Programs | 1 | 2023 | 23 | 0.050 |
Why?
|
| Adenoma | 1 | 2025 | 218 | 0.050 |
Why?
|
| Health Services | 1 | 2023 | 113 | 0.050 |
Why?
|
| Labor, Induced | 1 | 2022 | 40 | 0.050 |
Why?
|
| Technology | 1 | 2023 | 97 | 0.050 |
Why?
|
| Catheters | 1 | 2022 | 74 | 0.050 |
Why?
|
| Term Birth | 1 | 2022 | 25 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2025 | 2770 | 0.040 |
Why?
|
| Neoplasms | 1 | 2018 | 2913 | 0.040 |
Why?
|
| Joint Instability | 1 | 2024 | 183 | 0.040 |
Why?
|
| Sheep | 1 | 2024 | 876 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2001 | 28 | 0.040 |
Why?
|
| Hysteroscopy | 1 | 2021 | 14 | 0.040 |
Why?
|
| Hand Strength | 1 | 2002 | 144 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2024 | 849 | 0.040 |
Why?
|
| Tissue Adhesions | 1 | 2021 | 34 | 0.040 |
Why?
|
| Psychiatric Nursing | 1 | 2001 | 9 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2025 | 892 | 0.040 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2001 | 63 | 0.040 |
Why?
|
| Autonomic Nervous System | 1 | 2001 | 83 | 0.040 |
Why?
|
| Multigene Family | 1 | 2001 | 210 | 0.040 |
Why?
|
| Dissociative Disorders | 1 | 2001 | 30 | 0.040 |
Why?
|
| Cadaver | 2 | 2004 | 311 | 0.040 |
Why?
|
| Vaccines, Inactivated | 1 | 2021 | 70 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2025 | 1115 | 0.040 |
Why?
|
| Nurse-Patient Relations | 1 | 2001 | 67 | 0.040 |
Why?
|
| Equivalence Trials as Topic | 1 | 2020 | 35 | 0.040 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2020 | 47 | 0.040 |
Why?
|
| Vaccines, Attenuated | 1 | 2021 | 129 | 0.040 |
Why?
|
| Hip Prosthesis | 1 | 2000 | 42 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2008 | 1736 | 0.040 |
Why?
|
| Lateral Ventricles | 1 | 2000 | 32 | 0.040 |
Why?
|
| Social Networking | 1 | 2020 | 32 | 0.040 |
Why?
|
| Cerebral Revascularization | 1 | 2019 | 22 | 0.040 |
Why?
|
| Pragmatic Clinical Trials as Topic | 1 | 2020 | 133 | 0.040 |
Why?
|
| Inpatients | 1 | 2024 | 553 | 0.040 |
Why?
|
| Myocardial Ischemia | 1 | 2001 | 285 | 0.040 |
Why?
|
| Catheterization | 1 | 2000 | 184 | 0.040 |
Why?
|
| Hyaluronic Acid | 1 | 2021 | 226 | 0.040 |
Why?
|
| Maternal Age | 1 | 2019 | 128 | 0.040 |
Why?
|
| Lower Extremity | 1 | 2023 | 450 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2003 | 788 | 0.040 |
Why?
|
| Nursing Staff, Hospital | 1 | 2001 | 143 | 0.040 |
Why?
|
| Knee Joint | 1 | 2022 | 429 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2020 | 413 | 0.030 |
Why?
|
| Equipment Design | 1 | 2000 | 525 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2025 | 995 | 0.030 |
Why?
|
| Family | 1 | 2022 | 685 | 0.030 |
Why?
|
| Pharmacists | 1 | 2021 | 258 | 0.030 |
Why?
|
| Crohn Disease | 1 | 2001 | 260 | 0.030 |
Why?
|
| Awareness | 1 | 2018 | 110 | 0.030 |
Why?
|
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2017 | 28 | 0.030 |
Why?
|
| Heart Rate | 1 | 2001 | 856 | 0.030 |
Why?
|
| Educational Status | 1 | 2019 | 470 | 0.030 |
Why?
|
| Accessory Nerve | 1 | 1997 | 4 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2026 | 1154 | 0.030 |
Why?
|
| Internationality | 1 | 2018 | 156 | 0.030 |
Why?
|
| Phenotype | 1 | 2025 | 3170 | 0.030 |
Why?
|
| Patients | 1 | 2018 | 183 | 0.030 |
Why?
|
| Health Plan Implementation | 1 | 2018 | 141 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2017 | 221 | 0.030 |
Why?
|
| Mice | 2 | 2017 | 18355 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2001 | 976 | 0.030 |
Why?
|
| Insurance Coverage | 1 | 2018 | 244 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2025 | 1169 | 0.030 |
Why?
|
| Nurse Practitioners | 1 | 2018 | 141 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2019 | 560 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2018 | 1300 | 0.030 |
Why?
|
| Self Report | 1 | 2020 | 876 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 712 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2016 | 360 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2018 | 504 | 0.030 |
Why?
|
| Ergonomics | 1 | 2014 | 29 | 0.030 |
Why?
|
| Prescriptions | 1 | 2014 | 74 | 0.030 |
Why?
|
| Occupational Injuries | 1 | 2014 | 49 | 0.030 |
Why?
|
| Efficiency | 1 | 2014 | 103 | 0.030 |
Why?
|
| Abscess | 1 | 2014 | 77 | 0.030 |
Why?
|
| Decision Support Techniques | 1 | 2018 | 480 | 0.020 |
Why?
|
| Wound Infection | 1 | 2014 | 60 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2018 | 944 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2024 | 2344 | 0.020 |
Why?
|
| Sex Factors | 1 | 2019 | 2110 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 2967 | 0.020 |
Why?
|
| Medically Uninsured | 1 | 2014 | 132 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2001 | 2399 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2014 | 201 | 0.020 |
Why?
|
| Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2010 | 13 | 0.020 |
Why?
|
| Pharmaceutical Services | 1 | 2011 | 76 | 0.020 |
Why?
|
| Diet | 1 | 2017 | 1278 | 0.020 |
Why?
|
| Biomechanical Phenomena | 2 | 2004 | 860 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2014 | 868 | 0.020 |
Why?
|
| Exercise | 2 | 2014 | 2205 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 2933 | 0.010 |
Why?
|
| Rotation | 1 | 2004 | 121 | 0.010 |
Why?
|
| Posture | 1 | 2004 | 197 | 0.010 |
Why?
|
| Palliative Care | 1 | 2011 | 1022 | 0.010 |
Why?
|
| Range of Motion, Articular | 1 | 2004 | 429 | 0.010 |
Why?
|
| Machiavellianism | 1 | 2001 | 1 | 0.010 |
Why?
|
| Nursing Methodology Research | 1 | 2001 | 43 | 0.010 |
Why?
|
| Helping Behavior | 1 | 2001 | 19 | 0.010 |
Why?
|
| Linkage Disequilibrium | 1 | 2001 | 255 | 0.010 |
Why?
|
| Chromium Alloys | 1 | 2000 | 4 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2001 | 507 | 0.010 |
Why?
|
| Psychological Theory | 1 | 2001 | 93 | 0.010 |
Why?
|
| Bone Cements | 1 | 2000 | 39 | 0.010 |
Why?
|
| Durapatite | 1 | 2000 | 37 | 0.010 |
Why?
|
| Porosity | 1 | 2000 | 94 | 0.010 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2000 | 65 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2000 | 1378 | 0.010 |
Why?
|
| Social Support | 1 | 2001 | 651 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2001 | 2181 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 2001 | 1149 | 0.010 |
Why?
|